Vaccines and Beyond: Strategies and Technologies for mRNA Therapeutics
Webinar

Vaccines and Beyond: Strategies and Technologies for mRNA Therapeutics

An expert panel will discuss mRNA-based vaccines, current approaches and challenges, and how researchers are moving RNA therapeutics forward in exciting new directions.

Share

 LIVE Symposium

Tuesday, July 23, 2024
1:00 - 4:00 PM Eastern Time

The COVID-19 pandemic brought mRNA-based vaccines to the forefront. However, many challenges still exist in the field of RNA medicines, including identifying what additional diseases could be targeted and how best to deliver vaccines and other therapeutics.

In this virtual symposium brought to you by The Scientist, an expert panel will discuss mRNA-based vaccines, current approaches and challenges, and how researchers are moving RNA therapeutics forward in exciting new directions.

Symposium program

1:00 PM – Introduction

1:10 PM- Vaccines and Beyond: Strategies and Technologies for mRNA Therapeutics

Kathryn Whitehead, PhD

1:45 PM – Engineering Synthetic Biodegradable Lipid Nanoparticles for mRNA Vaccines

Qiaobing Xu, PhD

2:20 PM – Next-Generation RNA Vaccines & Therapies

Anna Blakney, PhD 

2:55 PM – Enabling high dose RNA vaccination for the development of a multivalent enterovirus vaccine

Jesse Erasmus, PhD

3:20 PM - Open panel Q&A session
Nathan Ni from The Scientist's Creative Services Team will be joined by the entire panel in an open question and answer session where presenters will address questions posed by the audience.

Whitehead

Kathryn Whitehead, PhD
Professor
Chemical Engineering and Biomedical Engineering
Carnegie Mellon University

Whitehead

Qiaobing Xu, PhD
Professor
Biomedical Engineering
Tufts University

Anna Blakney, PhD

Anna Blakney, PhD
Assistant Professor
Tier 2 Canada Research Chair
Michael Smith Laboratories and School of Biomedical Engineering
University of British Columbia

Anna Blakney, PhD

Jesse Erasmus, PhD
Director of Virology



Sponsored by

  • Acro 
  • Promega

Top Image Credit:

3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo
New Frontiers in Vaccine Development

New Frontiers in Vaccine Development

Sino

Products

Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide

Explore a Concise Guide to Optimizing Viral Transduction

A Visual Guide to Lentiviral Gene Delivery

Takara Bio
Inventia Life Science

Inventia Life Science Launches RASTRUM™ Allegro to Revolutionize High-Throughput 3D Cell Culture for Drug Discovery and Disease Research

An illustration of differently shaped viruses.

Detecting Novel Viruses Using a Comprehensive Enrichment Panel

Twist Bio